Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,946
datasets available to search
ShareScore release 0.9.0
Dataset results
5,946 results for “diabetes type 2”
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01606007. IPD Sharing: Not stated. Countries: 8. Publications: 3.
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02597049. IPD Sharing: YES. Countries: 9. Publications: 2.
A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients
ClinicalTrials.gov study NCT02453685. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
ClinicalTrials.gov study NCT00308139. IPD Sharing: Not stated. Countries: 2. Publications: 10.
Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients
ClinicalTrials.gov study NCT00707954. IPD Sharing: Not stated. Countries: 1. Publications: 1.
STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT
ClinicalTrials.gov study NCT04616027. IPD Sharing: NO. Countries: 1. Publications: 1.
Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone
ClinicalTrials.gov study NCT00121667. IPD Sharing: Not stated. Countries: 9. Publications: 7.
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
ClinicalTrials.gov study NCT05073692. IPD Sharing: NO. Countries: 1. Publications: 4.
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly
ClinicalTrials.gov study NCT05259033. IPD Sharing: YES. Countries: 14. Publications: 1.
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01807221. IPD Sharing: Not stated. Countries: 25. Publications: 4.
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01885208. IPD Sharing: Not stated. Countries: 13. Publications: 18.
Effect of High Intensity Interval Training and Ultrasound Cavitation on Lipid Profile in Type 2 Diabetes Patients
ClinicalTrials.gov study NCT06926725. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00700817. IPD Sharing: Not stated. Countries: 15. Publications: 14.
Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT00328627. IPD Sharing: Not stated. Countries: 19. Publications: 1.
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
ClinicalTrials.gov study NCT00082381. IPD Sharing: Not stated. Countries: 13. Publications: 3.
The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired
ClinicalTrials.gov study NCT03152084. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT03495102. IPD Sharing: YES. Countries: 16. Publications: 3.
The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes
ClinicalTrials.gov study NCT02269098. IPD Sharing: NO. Countries: 1. Publications: 3.
Ayurveda Diet & Lifestyle Protocol for Type 2 Diabetes: A Feasibility Study
ClinicalTrials.gov study NCT07400276. IPD Sharing: NO. Countries: 1. Publications: 3.
Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes
ClinicalTrials.gov study NCT04466618. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.